Javascript must be enabled to continue!
Respiratory care in muscular dystrophy
View through CrossRef
Abstract
Respiratory problems are a major cause of morbidity and mortality in the muscular dystrophies. Indeed, in Duchenne muscular dystrophy (DMD) respiratory complications are the cause of death in over 70 per cent of patients, and virtually all Duchenne patients will develop ventilatory insufficiency if they survive long enough. In the other muscular dystrophies the extent of respiratory compromise will depend on the degree of respiratory muscle involvement, the presence of a thoracic scoliosis and level of bulbar weakness. In congenital muscular dystrophy merosin negative individuals seem more prone to early respiratory failure than merosin positive patients. Ventilatory failure is relatively uncommon, although not unknown in facioscapulohumeral muscular dystrophy, and has a variable prevalence in limb girdle MD. Although ventilatory support has been used sporadically in neuromuscular patients with chronic ventilatory failure for over 50 years, in the last decade the use of non-invasive ventilation has had a significant impact on survival and long-term outcome, particularly in DMD patients. In this chapter the natural history of respiratory problems in the muscular dystrophies is discussed, with particular emphasis on monitoring, identifying high-risk patients, and the outcome of therapeutic interventions.
Title: Respiratory care in muscular dystrophy
Description:
Abstract
Respiratory problems are a major cause of morbidity and mortality in the muscular dystrophies.
Indeed, in Duchenne muscular dystrophy (DMD) respiratory complications are the cause of death in over 70 per cent of patients, and virtually all Duchenne patients will develop ventilatory insufficiency if they survive long enough.
In the other muscular dystrophies the extent of respiratory compromise will depend on the degree of respiratory muscle involvement, the presence of a thoracic scoliosis and level of bulbar weakness.
In congenital muscular dystrophy merosin negative individuals seem more prone to early respiratory failure than merosin positive patients.
Ventilatory failure is relatively uncommon, although not unknown in facioscapulohumeral muscular dystrophy, and has a variable prevalence in limb girdle MD.
Although ventilatory support has been used sporadically in neuromuscular patients with chronic ventilatory failure for over 50 years, in the last decade the use of non-invasive ventilation has had a significant impact on survival and long-term outcome, particularly in DMD patients.
In this chapter the natural history of respiratory problems in the muscular dystrophies is discussed, with particular emphasis on monitoring, identifying high-risk patients, and the outcome of therapeutic interventions.
Related Results
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background:
Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an ...
Organisatie van geestelijke gezondheidszorg voor mensen met een ernstige en persisterende mentale aandoening
Organisatie van geestelijke gezondheidszorg voor mensen met een ernstige en persisterende mentale aandoening
1 INTRODUCTION AND RESEARCH QUESTIONS 5 -- 2 GENERAL BACKGROUND: DEFINITIONS AND SCOPE OF THE STUDY 7 -- 2.1 CHRONIC AND COMPLEX MENTAL DISORDERS: DEFINITIONS AND SCOPE OF THE -- S...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background
Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Abstract
Duchenne Muscular Dystrophy is a rare, X-linked neuromuscular disorder that leads to progressive muscle degeneration, loss of ambulation, and premature m...
Duchene’s muscular dystrophy: a clinical case
Duchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the...

